Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2007
06/14/2007WO2007066147A1 Topical compositions for paediatric use
06/14/2007WO2007065845A1 Copolymers based on polyalkylene oxide-modified n-vinyl lactam copolymers
06/14/2007WO2007065743A1 Compounds for use in treating abnormal cell proliferation, and methods of producing same
06/14/2007WO2007065441A1 Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions
06/14/2007WO2007065440A1 Pre-compacted calcium-containing compositions
06/14/2007WO2007051071A3 Two-step method of functionalizing carbon allotropes and pegylated carbon allotropes made by such methods
06/14/2007WO2007048223A3 A gastric retention drug delivery system
06/14/2007WO2007035448A3 Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
06/14/2007WO2007034210A3 Deglycosylated anti-muc-1 antibodies and uses thereof
06/14/2007WO2007022255A3 Pharmaceutical formulations for sustained release
06/14/2007WO2007019845B1 Method for encapsulating therapeutic substances in cells
06/14/2007WO2007017901A3 Silver nanoparticle dispersion formulation
06/14/2007WO2006102659A3 CONJUGATES OF AN hGH MOIETY AND A POLYMER
06/14/2007WO2006089228A3 Conjugates of an epo moiety and a polymer
06/14/2007WO2006079641A3 Insulin derivatives conjugated with structurally well defined branched polymers
06/14/2007WO2006030291A3 Radiofluorinated peptides
06/14/2007US20070135505 Aralkyl ester soft drugs
06/14/2007US20070135381 Derivatives of branch-chain lipophilic molecular and uses thereof
06/14/2007US20070135379 Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle
06/14/2007US20070135356 Gamma aminobutyric acid antagonist; naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative disorders; analgesics; drug withdrawal
06/14/2007US20070135349 Method for increasing the serum half-life of a biologically active molecule
06/14/2007US20070135346 Prodrugs of CC-1065 analogs
06/14/2007US20070134744 Epothilone resistant cell lines
06/14/2007US20070134729 Novel antibacterial agents
06/14/2007US20070134719 Method of controlling pharmacokinetics of immunomodulatory compounds
06/14/2007US20070134342 Injectable carrier formulations of hyaluronic acid derivatives for delivery of osteogenic proteins
06/14/2007US20070134334 Crosslinked polysaccharide microparticles and method for their preparation
06/14/2007US20070134333 Methods of bonding or modifying hydrogels using irradiation
06/14/2007US20070134325 Beta-lactam antibiotic-containing tablet and production thereof
06/14/2007US20070134319 Pharmaceutical formulations of bisphosphonates
06/14/2007US20070134314 Therapeutic inhibitor of vascular smooth muscle cells
06/14/2007US20070134309 Agent containing ergoline for transdermal application
06/14/2007US20070134308 Non-steroidal anti-inflammatory drug formulations for topical applications to the skin
06/14/2007US20070134298 Dietary supplement
06/14/2007US20070134297 Device to aid in sexual pleasure
06/14/2007US20070134276 Microemulsions of retinoids, and pharmaceutical compositions containing them
06/14/2007US20070134268 Vaccines
06/14/2007US20070134206 Targeting proteins to deliver therapeutic or diagnostic reagents
06/14/2007US20070134199 a surface active substance, in particular a non-ionic detergent (tenside), and a mixture of at least two amino acids, are either Glu and Gln or Asp and Asn for stabilization of protein agents in pharmaceuticals
06/14/2007US20070134197 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
06/14/2007US20070134183 Aminosulfonic acid compounds for promoting desquamation of the skin
06/14/2007US20070134175 Reducing adverse reactions of the skin to chemicals e.g. topical cosmetic; side effect reduction
06/14/2007US20070134164 Fentanyl composition for nasal administration
06/14/2007US20070134160 Reagent system and method for modifying the luminescence of lanthanide(III) macrocyclic complexes
06/14/2007US20070134153 Lipid-based drug delivery systems against parasitic infections
06/14/2007DE19936997B4 Verfahren zur Applikation von Photosensibilisatoren (PS) mittels Multiplikatoren in der photodymamischen Therapie A process for the application of photosensitizers (PS) by means of multipliers in the therapy photodymamischen
06/14/2007DE10297513B4 In vitro Herstellung von dendritischen Zellen aus CD14+ Monocyten In vitro production of dendritic cells from CD14 + monocytes
06/14/2007DE102005059050A1 Cosmetic-/pharmaceutical composition, useful as hair treatment agent, hair wax or gel wax, and for modeling and/or forming a hairstyle, comprises hydrophobically modified polyol, polysaccharide, emulsifying agent, and fat material
06/14/2007DE102005058569A1 Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer Foam wafer with polyvinyl alcohol-polyethylene glycol graft
06/14/2007DE10103565B4 Zusammensetzungen, enthaltend einen Ruthenium(III)-komplex und einen Heterocyclus Compositions comprising a ruthenium (III) complex and a heterocycle
06/14/2007CA2856436A1 Uses of myostatin antagonists
06/14/2007CA2838111A1 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
06/14/2007CA2812968A1 Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
06/14/2007CA2633161A1 Methods and compositions for expanding t regulatory cells
06/14/2007CA2633110A1 Transdermal administration of active agents for systemic effect
06/14/2007CA2632855A1 Process for manufacturing chewable dosage forms for drug delivery and products thereof
06/14/2007CA2632682A1 In vivo cell surface engineering
06/14/2007CA2632663A1 Immunostimulatory compositions and methods
06/14/2007CA2632544A1 Use of myostatin antagonist for treating the effects of hypogonadism
06/14/2007CA2632067A1 Method for improving absorbability of epigallocatechin gallate, foods, drinks and food/drink materials using the same and method for producing the same
06/14/2007CA2631827A1 Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions
06/14/2007CA2631821A1 Pre-compacted calcium-containing compositions
06/14/2007CA2628756A1 Interleukin-11 compositions and methods of use
06/13/2007EP1795598A1 Novel peptides
06/13/2007EP1795207A1 Solid pharmaceutical preparation
06/13/2007EP1795187A1 Film forming composition comprising sucralose and carrageenan
06/13/2007EP1794288A1 The modulation of phagocytosis in neurons
06/13/2007EP1793870A2 Odour-reducing quinone compounds
06/13/2007EP1793863A2 Nanoparticles comprising antigens and adjuvants and immunogenic structure
06/13/2007EP1793862A2 A process for the preparation of a piroxicam: betacyclodextrin inclusion compound
06/13/2007EP1793861A1 An antimicrobial silver halide composition
06/13/2007EP1793860A1 Composition and method for medical imaging of body cavities
06/13/2007EP1793837A2 Fatty acid modified polylysines as antimicrobial agents
06/13/2007EP1793833A1 Multiple sclerosis treatment
06/13/2007EP1793814A2 Thyroid hormone analogs for promoting angiogenesis
06/13/2007EP1793813A2 Treatment of adhd
06/13/2007EP1793810A1 Nanoparticles and method for the production thereof
06/13/2007EP1793807A2 Multifunctional supramolecular hydrogels as biomaterials
06/13/2007EP1470146B1 Antibodies against the muc18 antigen
06/13/2007EP1456219B1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist
06/13/2007EP1455810B1 Pharmaceutical formulation comprising cyclosporin and use thereof
06/13/2007EP1438024B1 Process for dispersing a fluid in solid particles
06/13/2007EP1385552B1 Oral delivery method and composition for solid medications or dietary supplements
06/13/2007EP1381352B1 Transdermal patch for administering fentanyl
06/13/2007EP1363932B1 Amphoteric sterols and the use thereof
06/13/2007EP1289645B1 Zero order release and temperature-controlled microcapsules and process for the preparation thereof
06/13/2007EP1276474B1 Formulations for use in inhaler devices
06/13/2007EP1276469B1 Taste masking coating composition
06/13/2007EP1267925B1 Treatment of fungal infection with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
06/13/2007EP1244690B1 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent
06/13/2007EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof
06/13/2007EP1171104B1 Transdermal therapeutic system with neutralized acrylic adhesive patch
06/13/2007EP1069914B1 Controlled release tablet produced from linear water-insoluble polysaccharides
06/13/2007EP0975354B1 Ligand/lytic peptide compositions and methods of use
06/13/2007EP0914431B1 Truncated soluble tumor necrosis factor type-i receptors
06/13/2007CN1980974A Low molecular weight polymers
06/13/2007CN1980699A Treatment methods utilizing albumin-binding proteins as targets
06/13/2007CN1980695A Antigen delivery vectors and constructs
06/13/2007CN1980679A Glycyrrhizin-containing suppository compositions for rectal infusion
06/13/2007CN1980671A Liposome preparation containing slightly water-soluble camptothecin
1 ... 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 ... 1712